Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Cushing Syndrome I: Introduction

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Cushing Syndrome II: Pathophysiology

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

Hormones of the Adrenal Glands

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Interplay among sleep quality, dinner timing, and blood glucose control in users of advanced technologies: A study in a cohort of adults with type 1 diabetes.

Diabetes research and clinical practice·2025

Same author

Expert opinion on the management of patients with osteoporosis with anabolic drugs in Italy.

Reumatismo·2024

Same author

A universal UHPLC-CAD platform for the quantification of polysaccharide antigens.

Scientific reports·2023

Same author

Subclinical coronary atherosclerosis, detected by computer tomography with coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis.

European journal of internal medicine·2023

Same author

Postprandial glucose variability in type 1 diabetes: The individual matters beyond the meal.

Diabetes research and clinical practice·2022

Same author

Osteoblast role in the pathogenesis of rheumatoid arthritis.

Molecular biology reports·2021

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

Corticosteroids, a review.

N Melillo¹, A Corrado, L Quarta

¹Rheumatology Clinic, C. d'Avanzo, Hospital Foggia, Italy.

Panminerva Medica

|May 1, 2007

Summary

The neuroendocrine-immune system interaction is key to understanding rheumatoid arthritis (RA) pathogenesis. New theories suggest corticosteroid (CS) insufficiency in RA, prompting a re-evaluation of CS therapy and exploration of alternative treatments.

Area of Science:

Neuroimmunology
Endocrinology
Rheumatology

Background:

The nervous, endocrine, and immune systems are intricately interconnected.
Understanding these interactions is crucial for autoimmune disease pathogenesis, including rheumatoid arthritis (RA).
Emerging theories propose hypothalamic-pituitary-adrenal axis dysfunction leading to corticosteroid (CS) insufficiency in RA.

Purpose of the Study:

To explore the role of neuroendocrine-immune interactions in RA.
To investigate the implications of corticosteroid (CS) insufficiency in RA pathogenesis.
To evaluate the therapeutic potential of CS and alternative treatments in RA.

Main Methods:

Review of recent studies on neuroendocrine-immune system interactions.
Analysis of theories regarding hypothalamic-pituitary-adrenal axis response in RA.

Related Experiment Videos

Last Updated: Jul 15, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

Consideration of new therapeutic agents like anti-TNF and biohumoral markers.

Main Results:

A strong correlation exists between the nervous, endocrine, and immune systems.
RA may involve an inadequate hypothalamic-pituitary-adrenal axis response to pro-inflammatory cytokines, causing CS insufficiency.
Recent findings question the benefits of CS on joint damage, highlighting anti-TNF agents and new markers like cartilage oligomeric matrix protein.

Conclusions:

Neuroendocrine-immune system crosstalk is vital for RA understanding and treatment.
Corticosteroid (CS) insufficiency is a potential factor in RA, necessitating re-evaluation of CS therapy.
Alternative therapies, including anti-TNF agents and novel biomarkers, offer promising avenues for RA management.